Quarterly report pursuant to Section 13 or 15(d)

Unaudited Interim Condensed Consolidated Balance Sheets

v3.22.1
Unaudited Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,496 $ 2,595
Restricted cash 1,680 630
Accounts receivable 6,019 5,548
Short-term investments (cost: March 31, 2022 - $268,702; December 31, 2021 - $280,263) 266,560 279,374
Prepaid expenses and other current assets 8,503 6,798
Total current assets 285,258 294,945
Non-current assets:    
Property and equipment, net 2,333 2,045
Investment in joint venture 200 200
Intangible assets, net 23,670 24,421
Goodwill 13,328 13,328
Operating right-of-use asset 958 713
Other non-current assets 880 232
Total assets 326,627 335,884
Current liabilities:    
Accounts payable and accrued expenses 9,012 6,369
Deferred revenue 6,281 5,976
Operating lease liability, current 496 438
Total current liabilities 15,789 12,783
Non-current liabilities:    
Warrant liability 28,758 31,308
Operating lease liability, long-term 466 278
Deferred tax liability 144 144
Total liabilities 45,157 44,513
Commitments and Contingencies (Note 10)
Stockholders' Equity    
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at March 31, 2022 and December 31, 2021. No shares issued and outstanding at March 31, 2022 and December 31, 2021. 0 0
Common stock, $0.0001 par value; 400,000,000 authorized; 70,845,636 and 70,667,381 shares issued at March 31, 2022 and December 31, 2021, respectively. 7 7
Additional paid-in capital 370,794 368,680
Accumulated other comprehensive loss (1,901) (898)
Accumulated deficit (87,430) (76,418)
Total stockholders' equity 281,470 291,371
Total Liabilities and Stockholders' Equity $ 326,627 $ 335,884